Maryland Community Newspapers Online
Medical insurance reform, workplace regulation and civil liability will be among the key topics at the Maryland Chamber of Commerce's annual Business Policy Conference, which runs Thursday and Friday at the Hyatt Regency Chesapeake Bay Golf Resort, Spa and Marina in Cambridge.
The conference is one of several this week involving state organizations. The Maryland Tourism and Travel Summit, coordinated by the Maryland Tourism Council, will be held Wednesday through Friday at the Ocean City Convention Center and Hilton Suites Oceanfront. The Mid-Atlantic Bio Conference, whose sponsors include the MdBio division of the Tech Council of Maryland, is slated for Wednesday through Friday at the Washington Convention Center.
Scheduled speakers at the Maryland chamber conference include William Longbrake, executive-in-residence and senior policy adviser for the new Center for Financial Policy at the University of Maryland, College Park. He plans to give an economic update for Maryland during the luncheon Thursday.
Gov. Martin O'Malley (D) is slated to speak at that evening's dinner. The General Assembly's presiding officers and minority leaders will give their outlook for the 2010 session on Friday morning.
Panel discussions on civil liability, clean energy and CEO perspectives are scheduled Thursday afternoon. Talks on medical insurance reform and workplace regulation are planned Friday morning.
Scheduled speakers at the tourism meeting include Anirban Basu, CEO of Baltimore economic and policy consulting firm Sage Policy Group, who will speak Wednesday afternoon on the state's economy. Peter Shankman, CEO of New York public relations firm Geek Factory, will discuss online marketing. Florida brand management company executive Bruce Turkel and O'Malley are among other speakers.
The bio conference's speakers list includes former presidential candidate and Vermont Gov. Howard Dean (D), a physician, discussing how reform will affect the biotechnology industry. Other speakers are MedImmune president Tony Zook and Human Genome Sciences CEO H. Thomas Watkins.